In this systematic review, A JAK2 V617F mutation was found in 31%, a CALR mutation in 10%, and a MPL mutation in 2% of patients [11], showing a much higher rate of triple negative disease (57%) than is reported in adults with ET (12%) [17]. This evidence concerns the gene JAK2 and essential thrombocythemia.